Detalhe da pesquisa
1.
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.
Bioeng Transl Med
; 8(1): e10363, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36684069
2.
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.
Cancers (Basel)
; 13(8)2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33918978
3.
PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis.
Nat Commun
; 11(1): 3520, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665551
4.
MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma.
Biochim Biophys Acta Gene Regul Mech
; 1861(3): 235-245, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408445
5.
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisacting DNA elements that govern muscle dystrophin expression.
Biochim Biophys Acta Gene Regul Mech
; 1860(11): 1138-1147, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28867298